Abstract
Two patients with coronavirus disease 2019 (COVID-19) infection (65 and 67 years old, receiving oxygen therapy via high-flow nasal cannulae, with no history of chronic respiratory disease or hemoptysis) were treated for psoas hematomata secondary to therapeutic anticoagulation (1 patient for a subsegmental pulmonary embolism and the other for an elevation of D-dimer level). In both the patients, computed tomography of the chest showed typical features of parenchymal lung abnormalities, consistent with COVID-19, and no chronic thromboembolic disease, bronchiectasis, or other conditions associated with bronchial artery dilatation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
